Heteronemin, a spongean sesterterpene, induces cell apoptosis and autophagy in human renal carcinoma cells

Szu Ying Wu, Ping Jyun Sung, Ya Ling Chang, Shiow Lin Pan, Che Ming Teng

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Heteronemin is a bioactive marine sesterterpene isolated from the sponge Hyrtios sp. Previous reports have shown that heteronemin possesses anticancer activity. Here, heteronemin displayed cytotoxic effects against three human cancer cell lines (A549, ACHN, and A498) and exhibited potent activity in A498 human renal carcinoma cells, with an ICvalue of 1.57 M by MTT assay and a GIvalue of 0.77 M by SRB assay. Heteronemin initiates apoptotic cell death by downregulating Bcl-2 and Bcl-xL and upregulating Bax, leading to the disruption of the mitochondrial membrane potential and the release of cytochrome c from the mitochondria. These effects were associated with the activation of caspase-3/caspase-8/caspase-9, followed by PARP cleavage. Furthermore, heteronemin inhibited the phosphorylation of AKT signaling pathway and ERK and activated p38 and JNK. The specific inhibition of the p38 pathway by SB203580 or p38 siRNA treatment reversed the heteronemin-induced cytotoxicity and apoptotic signaling. Heteronemin also induced autophagy in A498 cells, and treatment with chloroquine (autophagy inhibitor) or SP600125 (JNK inhibitor) inhibited autophagy and increased heteronemin-induced cytotoxicity and apoptotic signaling. Taken together, this study proposes a novel treatment paradigm in which the combination of heteronemin and autophagy inhibitors leads to enhanced RCC cell apoptosis.

Original languageEnglish
Article number738241
JournalBioMed Research International
Volume2015
DOIs
Publication statusPublished - 2015

Fingerprint

Sesterterpenes
Autophagy
Renal Cell Carcinoma
Cells
Apoptosis
Cytotoxicity
Assays
heteronemin
Phosphorylation
Mitochondria
Caspase 9
Caspase 8
MAP Kinase Signaling System
Mitochondrial Membrane Potential
Chloroquine
Porifera
Cell death
Cytochromes c
Caspase 3
Small Interfering RNA

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)

Cite this

Heteronemin, a spongean sesterterpene, induces cell apoptosis and autophagy in human renal carcinoma cells. / Wu, Szu Ying; Sung, Ping Jyun; Chang, Ya Ling; Pan, Shiow Lin; Teng, Che Ming.

In: BioMed Research International, Vol. 2015, 738241, 2015.

Research output: Contribution to journalArticle

@article{50450257eb314c31af43337565284da1,
title = "Heteronemin, a spongean sesterterpene, induces cell apoptosis and autophagy in human renal carcinoma cells",
abstract = "Heteronemin is a bioactive marine sesterterpene isolated from the sponge Hyrtios sp. Previous reports have shown that heteronemin possesses anticancer activity. Here, heteronemin displayed cytotoxic effects against three human cancer cell lines (A549, ACHN, and A498) and exhibited potent activity in A498 human renal carcinoma cells, with an ICvalue of 1.57 M by MTT assay and a GIvalue of 0.77 M by SRB assay. Heteronemin initiates apoptotic cell death by downregulating Bcl-2 and Bcl-xL and upregulating Bax, leading to the disruption of the mitochondrial membrane potential and the release of cytochrome c from the mitochondria. These effects were associated with the activation of caspase-3/caspase-8/caspase-9, followed by PARP cleavage. Furthermore, heteronemin inhibited the phosphorylation of AKT signaling pathway and ERK and activated p38 and JNK. The specific inhibition of the p38 pathway by SB203580 or p38 siRNA treatment reversed the heteronemin-induced cytotoxicity and apoptotic signaling. Heteronemin also induced autophagy in A498 cells, and treatment with chloroquine (autophagy inhibitor) or SP600125 (JNK inhibitor) inhibited autophagy and increased heteronemin-induced cytotoxicity and apoptotic signaling. Taken together, this study proposes a novel treatment paradigm in which the combination of heteronemin and autophagy inhibitors leads to enhanced RCC cell apoptosis.",
author = "Wu, {Szu Ying} and Sung, {Ping Jyun} and Chang, {Ya Ling} and Pan, {Shiow Lin} and Teng, {Che Ming}",
year = "2015",
doi = "10.1155/2015/738241",
language = "English",
volume = "2015",
journal = "BioMed Research International",
issn = "2314-6133",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Heteronemin, a spongean sesterterpene, induces cell apoptosis and autophagy in human renal carcinoma cells

AU - Wu, Szu Ying

AU - Sung, Ping Jyun

AU - Chang, Ya Ling

AU - Pan, Shiow Lin

AU - Teng, Che Ming

PY - 2015

Y1 - 2015

N2 - Heteronemin is a bioactive marine sesterterpene isolated from the sponge Hyrtios sp. Previous reports have shown that heteronemin possesses anticancer activity. Here, heteronemin displayed cytotoxic effects against three human cancer cell lines (A549, ACHN, and A498) and exhibited potent activity in A498 human renal carcinoma cells, with an ICvalue of 1.57 M by MTT assay and a GIvalue of 0.77 M by SRB assay. Heteronemin initiates apoptotic cell death by downregulating Bcl-2 and Bcl-xL and upregulating Bax, leading to the disruption of the mitochondrial membrane potential and the release of cytochrome c from the mitochondria. These effects were associated with the activation of caspase-3/caspase-8/caspase-9, followed by PARP cleavage. Furthermore, heteronemin inhibited the phosphorylation of AKT signaling pathway and ERK and activated p38 and JNK. The specific inhibition of the p38 pathway by SB203580 or p38 siRNA treatment reversed the heteronemin-induced cytotoxicity and apoptotic signaling. Heteronemin also induced autophagy in A498 cells, and treatment with chloroquine (autophagy inhibitor) or SP600125 (JNK inhibitor) inhibited autophagy and increased heteronemin-induced cytotoxicity and apoptotic signaling. Taken together, this study proposes a novel treatment paradigm in which the combination of heteronemin and autophagy inhibitors leads to enhanced RCC cell apoptosis.

AB - Heteronemin is a bioactive marine sesterterpene isolated from the sponge Hyrtios sp. Previous reports have shown that heteronemin possesses anticancer activity. Here, heteronemin displayed cytotoxic effects against three human cancer cell lines (A549, ACHN, and A498) and exhibited potent activity in A498 human renal carcinoma cells, with an ICvalue of 1.57 M by MTT assay and a GIvalue of 0.77 M by SRB assay. Heteronemin initiates apoptotic cell death by downregulating Bcl-2 and Bcl-xL and upregulating Bax, leading to the disruption of the mitochondrial membrane potential and the release of cytochrome c from the mitochondria. These effects were associated with the activation of caspase-3/caspase-8/caspase-9, followed by PARP cleavage. Furthermore, heteronemin inhibited the phosphorylation of AKT signaling pathway and ERK and activated p38 and JNK. The specific inhibition of the p38 pathway by SB203580 or p38 siRNA treatment reversed the heteronemin-induced cytotoxicity and apoptotic signaling. Heteronemin also induced autophagy in A498 cells, and treatment with chloroquine (autophagy inhibitor) or SP600125 (JNK inhibitor) inhibited autophagy and increased heteronemin-induced cytotoxicity and apoptotic signaling. Taken together, this study proposes a novel treatment paradigm in which the combination of heteronemin and autophagy inhibitors leads to enhanced RCC cell apoptosis.

UR - http://www.scopus.com/inward/record.url?scp=84930613524&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930613524&partnerID=8YFLogxK

U2 - 10.1155/2015/738241

DO - 10.1155/2015/738241

M3 - Article

C2 - 26090440

AN - SCOPUS:84930613524

VL - 2015

JO - BioMed Research International

JF - BioMed Research International

SN - 2314-6133

M1 - 738241

ER -